Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung

Clinical trial NCT00039182 · COMPLETED

Trial details

NCT number: NCT00039182
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Mesothelioma Epithelial Mesothelioma Recurrent Malignant Mesothelioma Sarcomatous Mesothelioma

Start date: 2002-05-01
Primary completion: 2007-06-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.